COMP <GO>
ICFI vs AMN // ALTMAN Z-SCORE & DEBT/EQUITY
ICF International Inc. (NASDAQ) VS. AMN Healthcare Services Inc (NYSE) • 15-METRIC TALLY: ICFI 8
— AMN 3
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: ICFI
LAST: $95.84 (+1.25%) • MKT CAP: $1.72B
balance-sheet
2.87
LAST: $46.94 (+0.47%) • MKT CAP: $1.82B
balance-sheet
2.76
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICFI VS. AMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICFI | AMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 37.20% | 28.30% | +8.90 | ICFI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.10% | -7.20% | +15.30 | ICFI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.25% | 12.86% | -4.61 | AMN | /fcf-yield <GO> |
| Operating Margin | 7.80% | -2.00% | +9.80 | ICFI | /operating-margins <GO> |
| Net Profit Margin | 4.90% | -3.50% | +8.40 | ICFI | /net-margins <GO> |
| Revenue Growth (YoY) | -7.30% | -8.50% | +1.20 | ICFI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.60% | 0.00% | +0.60 | ICFI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.87 | 2.76 | +0.11 | ICFI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | ICFI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.6 | 75.9 | -5.28 | AMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.4x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.72B | $1.82B | -$99.2M | AMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICFI REV | AMN REV | ICFI GROSS % | AMN GROSS % | ICFI FCF | AMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.87B | $2.73B | 37.2% | 28.3% | $141.9M | $233.8M |
| FY 2024 | $2.02B | $2.98B | 36.5% | 30.8% | $171.5M | $239.5M |
| FY 2023 | $1.96B | $3.79B | — | — | $152.4M | $372.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICFI // BETA —
AMN // BETA —